In this free webinar, learn how one institution successfully implemented a rapid multiplex blood culture identification panel into their antimicrobial stewardship program. Attendees will learn how rapid blood culture identification results can improve the management of patients with bacteremia. The featured speaker will discuss how to identify outcomes that can be used to demonstrate the value of rapid blood culture identification.
TORONTO, May 14, 2024 /PRNewswire-PRWeb/ -- Bloodstream infections are a common cause of morbidity and mortality despite advances in antimicrobial agents and sepsis management. Over the past decade, several molecular methods have been integrated into routine clinical microbiology workflows due to their ability to rapidly and simultaneously detect microorganisms and antimicrobial resistance genes from positive blood cultures.
Incorporating a rapid multiplex molecular blood culture identification (BCID) panel can be an important strategy to improve the outcomes of patients with bacteremia and improve antimicrobial utilization. However, the impact on clinical outcomes is only realized when rapid BCID results are partnered with active stewardship interventions.
In this webinar, the expert speaker will share insights gained through the implementation of a rapid syndromic cobas® eplex BCID panels in tandem with real-time antimicrobial stewardship interventions, which resulted in improved antimicrobial use and patient outcomes at a large academic medical center.
This webinar focuses on the integration of rapid blood culture identification into an antimicrobial stewardship program, how antimicrobial stewardship programs make rapid BCID results actionable and how the results can be used to demonstrate the value of the test and impact on antimicrobial stewardship.
Register for this webinar today to understand how active diagnostic stewardship interventions can help optimize the outcomes of patients with bacteremia.
Join Ryan Shields, PharmD, MS, Associate Professor of Medicine, University of Pittsburgh, Department of Medicine, for the live webinar on Thursday, May 30, 2024, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Leveraging Active Diagnostic Stewardship Interventions to Optimize the Outcomes of Patients with Bacteremia.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article